| Literature DB >> 7903572 |
L Baillargeon1, J Drouin, L Desjardins, D Leroux, D Audet.
Abstract
The purpose of this study, which took the form of a two-period cross-over clinical trial, was to determine whether a homeopathic substance, Arnica Montana, significantly decreased bleeding time (Simplate II) and to describe its impact on various blood coagulation tests. It was not shown that this substance had a significant impact on various parameters of blood coagulation in healthy volunteers in the period immediately following administration [corrected].Entities:
Mesh:
Substances:
Year: 1993 PMID: 7903572 PMCID: PMC2379941
Source DB: PubMed Journal: Can Fam Physician ISSN: 0008-350X Impact factor: 3.275